Could the trade mount a legal challenge vs NDI guidance?
If the Food and Drug Administration (FDA) does not revise its draft guidance on new dietary ingredients (NDIs) for supplements to reflect industry concerns, the trade might be stuck between a rock and a hard place, admit lawyers.

Are Two FDA Approvals in One Week a Positive Sign?
Don't count on it.